Clal Insurance Enterprises Holdings Ltd raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 61.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 691,000 shares of the exchange traded fund’s stock after buying an additional 263,000 shares during the period. Clal Insurance Enterprises Holdings Ltd’s holdings in SPDR S&P Biotech ETF were worth $84,254,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in XBI. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $30,000. Legacy Wealth Managment LLC ID bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $32,000. Greykasell Wealth Strategies Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $35,000. Ballast Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $36,000. Finally, Creative Financial Designs Inc. ADV bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $39,000.
SPDR S&P Biotech ETF Stock Up 0.8%
XBI opened at $133.79 on Friday. The firm has a market cap of $8.54 billion, a PE ratio of 11.47 and a beta of 0.85. The business has a fifty day simple moving average of $132.63 and a 200-day simple moving average of $127.12. SPDR S&P Biotech ETF has a fifty-two week low of $80.90 and a fifty-two week high of $139.19.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
